Dropcys (mercaptamine)
Orphan
- Region
- 🇪🇺 EU
- Active substance
- mercaptamine
- Company
- Lucane Pharma
- Status
- Refused
- Therapeutic area
- Corneal Diseases; Cystinosis
- CHMP opinion
- Fri 01 Apr 2016
- Designations
- Orphan
- Application
- EMEA/H/C/004038
- ATC
- S01XA21
- Official record
- www.ema.europa.eu
Indication
Treatment of corneal cystine deposits
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Procysbi Authorised · Chiesi Farmaceutici S.p.A
- 🇪🇺 Cystadrops Authorised · Recordati Rare Diseases
- 🇪🇺 Cystagon Authorised · Recordati Rare Diseases
Follow Dropcys
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.